The FDA sends another warning letter to Hospira, this time over problems found at an Italian pharmaceutical plant.
Get the complete picture with a MassDevice Plus membership. Registered users can login here.
Former Allergan CEO David Pyott will not get a seat on the board at Actavis after all, now that their $70 billion merger is done.
Bayer says it plans to grow its main healthcare division by 6% annually over the next 3 years.
Medtronic invests in anti-leg-cramp drug maker Flex Pharma's initial public offering.
Pfizer looks to bolster its generics footprint with a $15 billion bid for Hospira.
Allergan agrees to a $66 billion takeover bid from Actavis, thwarting a hostile takeover bid by Valeant Pharmaceuticals and William Ackman's Pershing Square Capital Management.
Allergan is close to sealing a deal worth nearly $66 billion with Actavis and giving the slip to a hostile takeover bid from Valeant Pharmaceuticals and William Ackman's Pershing Square hedge fund.
Need Medtech news in a minute? We Deliver!
MassDevice +3,+5 and +7 newsletters get you caught up on all the mission critical news you need in med tech. Sign up today for our free newsletter.
News and information for the medical device industry and the companies that drive it. Learn the latest about sales, jobs, legislation and other areas of the medtech industry.